Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rβ2 inhibition

Annals of the Rheumatic Diseases

Volumn 69, Issue 8, 2010, Pages 1562-1567

  Toh, Myew Ling ^a   Kawashima, Masanori ^a   Hot, Arnaud ^a   Miossec, Philippe ^a   Miossec, Pierre ^a  

^a UNIVERSITÉ DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; NEUTROPHIL COLLAGENASE; TRANSCRIPTION FACTOR T BET;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR BLOCKING; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; TH1 CELL;

ADULT; ARTHRITIS, RHEUMATOID; CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MIDDLE AGED; MONOCYTES; RECEPTORS, INTERLEUKIN-12; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SYNOVIAL MEMBRANE; T-BOX DOMAIN PROTEINS; TH1 CELLS;

EID: 77955445597     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.111757     Document Type: Article

References (20)

1. Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
2. Kawashima M, Miossec P. Decreased response to IL-12 and IL-18 of peripheral blood cells in rheumatoid arthritis. Arthritis Res Ther 2004;6:R39-45.
3. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009;361:888-98.
4. Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005;6:1123-32.
5. Szabo SJ, Sullivan BM, Stemmann C, et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002;295:338-42.
6. Szabo SJ, Dighe AS, Gubler U, et al. Regulation of the interleukin (IL-)-12R beta 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J Exp Med 1997;185:817-24. (Pubitemid 27119865)
7. Cruz A, Khader SA, Torrado E, et al. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 2006;177:1416-20. (Pubitemid 44092473)
8. Toh ML, Kawashima M, Zrioual S, et al. IL-17 inhibits human Th1 differentiation through IL-12R beta 2 downregulation. Cytokine 2009;48:226-30.
9. Toh ML, Marotte H, Blond JL, et al. Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment. Arthritis Rheum 2006;54:2109-18. (Pubitemid 44051066)
10. Chomarat P, Rissoan MC, Banchereau J, et al. Interferon gamma inhibits interleukin 10 production by monocytes. J Exp Med 1993;177:523-7. (Pubitemid 23117103)
11. Miossec P. Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy. Arthritis Rheum 2003;48:594-601. (Pubitemid 36301993)
12. Kirkham BW, Lassere MN, Edmonds JP, et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 2006;54:1122-31.
13. Zhang GX, Yu S, Gran B, et al. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J Immunol 2003;171:4485-92. (Pubitemid 37310563)
14. Chu CQ, Swart D, Alcorn D, et al. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum 2007;56:1145-51. (Pubitemid 46608639)
15. Nakae S, Iwakura Y, Suto H, et al. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol 2007;81:1258-68. (Pubitemid 46702045)
16. Kawashima M, Miossec P. Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL-4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity. Ann Rheum Dis 2005;64:415-18. (Pubitemid 40283052)
17. Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-8.
18. Chung Y, Chang SH, Martinez GJ, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 2009;30:576-87.
19. Takayanagi H, Ogasawara K, Hida S, et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000;408:600-5.
20. Sato K, Suematsu A, Okamoto K, et al. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med 2006;203:2673-82. (Pubitemid 44833343)